Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Glyburide - Generic Drug Details

« Back to Dashboard
Glyburide is the generic ingredient in seven branded drugs marketed by Sanofi Aventis Us, Aurobindo Pharma, Heritage Pharms Inc, Actavis Elizabeth, Zydus Pharms Usa Inc, Pharmacia And Upjohn, Corepharma, Sandoz, Pharmadax Inc, Teva, Hikma, Dava Pharms Inc, Mylan, Impax Labs Inc, and Bristol Myers Squibb, and is included in twenty-five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for glyburide. Forty-six suppliers are listed for this compound.

Summary for Generic Name: glyburide

Drug Master File Entries: see list20
Suppliers / Packagers: see list46
Bulk Api Vendors: see list84
Clinical Trials: see list20
Patent Applications: see list9,513
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:glyburide at DailyMed

Pharmacology for Ingredient: glyburide

Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
glyburide; metformin hydrochloride
TABLET;ORAL076821-002Jan 27, 2005DISCNNoNo► subscribe► subscribe
Zydus Pharms Usa Inc
TABLET;ORAL206749-003May 10, 2016RXNoNo► subscribe► subscribe
Dava Pharms Inc
TABLET;ORAL074591-003Dec 22, 1997RXNoNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: glyburide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
TABLET;ORAL017498-003May 1, 19843,454,635► subscribe
Pharmacia And Upjohn
TABLET;ORAL020051-003Sep 24, 19934,916,163► subscribe
Pharmacia And Upjohn
TABLET;ORAL017498-001May 1, 19843,454,635► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.